7.42
5.02%
0.35
Precedente Chiudi:
$7.07
Aprire:
$7.07
Volume 24 ore:
58,912
Relative Volume:
0.12
Capitalizzazione di mercato:
$430.19M
Reddito:
$299.48M
Utile/perdita netta:
$-86.45M
Rapporto P/E:
-2.7687
EPS:
-2.68
Flusso di cassa netto:
$-17.32M
1 W Prestazione:
+4.72%
1M Prestazione:
-17.68%
6M Prestazione:
+21.72%
1 anno Prestazione:
-18.59%
Health Catalyst Inc Stock (HCAT) Company Profile
Nome
Health Catalyst Inc
Settore
Industria
Telefono
801-708-6800
Indirizzo
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Confronta HCAT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
7.428 | 430.19M | 299.48M | -86.45M | -17.32M | -1.50 |
VEEV
Veeva Systems Inc
|
212.74 | 34.13B | 2.66B | 665.91M | 1.08B | 4.05 |
SOLV
Solventum Corp
|
66.12 | 11.41B | 8.26B | 66.00M | 1.17B | 0.3682 |
DOCS
Doximity Inc
|
53.84 | 9.97B | 516.85M | 174.11M | 217.38M | 0.87 |
HQY
Healthequity Inc
|
96.93 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
WAY
Waystar Holding Corp
|
36.76 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-04-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2024-01-03 | Iniziato | Barclays | Overweight |
2024-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
2023-12-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
2023-11-13 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2023-08-01 | Iniziato | Cantor Fitzgerald | Overweight |
2023-05-10 | Downgrade | Guggenheim | Buy → Neutral |
2023-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
2023-04-20 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2023-04-12 | Iniziato | Stephens | Equal-Weight |
2023-04-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
2022-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2022-09-13 | Downgrade | Piper Sandler | Overweight → Neutral |
2022-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
2022-08-05 | Downgrade | Stifel | Buy → Hold |
2022-04-14 | Iniziato | Guggenheim | Buy |
2022-03-17 | Aggiornamento | Jefferies | Hold → Buy |
2022-02-11 | Iniziato | Goldman | Buy |
2021-12-02 | Iniziato | Jefferies | Hold |
2021-10-14 | Iniziato | BTIG Research | Buy |
2021-04-29 | Ripresa | JP Morgan | Overweight |
2020-12-08 | Iniziato | Berenberg | Buy |
2020-07-14 | Iniziato | Citigroup | Buy |
2020-06-18 | Iniziato | Stifel | Buy |
2020-06-15 | Ripresa | Evercore ISI | Outperform |
2020-05-15 | Iniziato | Guggenheim | Buy |
2020-04-21 | Iniziato | RBC Capital Mkts | Outperform |
2020-04-13 | Iniziato | SVB Leerink | Outperform |
2020-04-02 | Iniziato | Canaccord Genuity | Buy |
2019-12-20 | Iniziato | Raymond James | Strong Buy |
2019-10-30 | Iniziato | Cantor Fitzgerald | Overweight |
2019-08-19 | Iniziato | Evercore ISI | Outperform |
2019-08-19 | Iniziato | Goldman | Buy |
2019-08-19 | Iniziato | JP Morgan | Overweight |
2019-08-19 | Iniziato | Piper Jaffray | Overweight |
2019-08-19 | Iniziato | SVB Leerink | Outperform |
2019-08-19 | Iniziato | SunTrust | Buy |
2019-08-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Health Catalyst Inc Borsa (HCAT) Ultime notizie
Health Catalyst, Inc. (NASDAQ:HCAT) Director Duncan Gallagher Sells 4,500 Shares - MarketBeat
Health Catalyst director Gallagher Duncan sells $31,415 in stock By Investing.com - Investing.com Australia
Health Catalyst director Gallagher Duncan sells $31,415 in stock - Investing.com India
Shareholders in Health Catalyst (NASDAQ:HCAT) are in the red if they invested three years ago - Yahoo Finance
How to Take Advantage of moves in (HCAT) - Stock Traders Daily
Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail
Health Catalyst (HCAT): Buy, Sell, Or Hold Post Q3 Earnings? - Barchart
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Brokerages Set Health Catalyst, Inc. (NASDAQ:HCAT) Target Price at $11.79 - MarketBeat
Health Catalyst (NASDAQ:HCAT shareholders incur further losses as stock declines 13% this week, taking three-year losses to 81% - Simply Wall St
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells 6,442 Shares of Stock - MarketBeat
Insider Sell: Linda Llewelyn Sells Shares of Health Catalyst Inc (HCAT) - GuruFocus.com
Health Catalyst: Improved Demand Environment Reinforces My Buy Rating (NASDAQ:HCAT) - Seeking Alpha
Healthcare Analytics Market Size, Trends, Growth, - openPR
Health Catalyst leaders share 2025 predictions - Modern Healthcare
Health Catalyst's SWOT analysis: stock outlook amid healthcare IT evolution By Investing.com - Investing.com South Africa
Health Catalyst's SWOT analysis: stock outlook amid healthcare IT evolution - Investing.com
Health Catalyst CFO Jason Alger sells shares worth $163,049 By Investing.com - Investing.com South Africa
Health Catalyst To Participate In Upcoming Investor Conference - Barchart
Health Catalyst CFO Jason Alger sells shares worth $163,049 - Investing.com India
Health Catalyst general counsel Landry Benjamin sells $160,294 in stock By Investing.com - Investing.com Nigeria
Health Catalyst general counsel Landry Benjamin sells $160,294 in stock - Investing.com
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Health Catalyst to Present at J.P. Morgan's 43rd Annual Healthcare Conference - StockTitan
Point72 Asset Management L.P. Increases Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Jacobs Levy Equity Management Inc. Has $913,000 Position in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare - Kilgore News Herald
Health Catalyst COO Daniel LeSueur sells shares worth $175,242 By Investing.com - Investing.com Australia
Health Catalyst COO Daniel LeSueur sells shares worth $175,242 - Investing.com India
Health Catalyst Signs Definitive Agreement to Acquire Top-Rated Cybersecurity Provider, Intraprise Health - Healthcare IT Today
(HCAT) Proactive Strategies - Stock Traders Daily
Health Catalyst chief commercial officer sells $67,073 in stock By Investing.com - Investing.com Canada
Fred Alger Management LLC Makes New $6.86 Million Investment in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Has $1.07 Million Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Millrace Asset Group Inc. Buys New Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst (NASDAQ:HCAT) Given "Overweight" Rating at Piper Sandler - MarketBeat
Piper Sandler raises Health Catalyst target to $12 on growth outlook - Investing.com Nigeria
GSA Capital Partners LLP Decreases Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Trend Tracker for (HCAT) - Stock Traders Daily
Health Catalyst (STU:2YP) Earnings Yield (Joel Greenblatt) % : -14.33% (As of Sep. 2024) - GuruFocus.com
Insider Sale: Chief People Officer Linda Llewelyn Sells Shares o - GuruFocus.com
Health Catalyst to Participate in Upcoming Investor Conferences - The Manila Times
Health Catalyst Leadership to Present at Three Major Healthcare Conferences in December | HCAT Stock News - StockTitan
Health Catalyst Inc Azioni (HCAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Health Catalyst Inc Azioni (HCAT) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Gallagher Duncan | Director |
Dec 23 '24 |
Sale |
6.98 |
4,500 |
31,415 |
74,438 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):